Novo Nordisk is accused in a suit of failing to warn that weight loss drug Ozempic could cause blindness. The plaintiff, a Maryland man, claims he developed non-arteritic anterior ischemic optic ...

The lawsuits allege that Ozempic causes a rare eye condition called NAION, or non-arteritic anterior ischemic optic neuropathy, which is akin to an eye stroke. All but one of the cases were filed ...

The Engels have now filed a lawsuit against Novo Nordisk, the maker of Ozempic, claiming the drug triggered the condition that robbed him of his sight. He says he was never warned of the ...

Todd Engel, 62, was prescribed Ozempic in 2023 to manage his Type 2 diabetes. The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy ...

You’ll use a new pen for each dose. »Learn more about Ozempic’s dosage for other conditions it’s prescribed to treat. »Get a detailed overview of Wegovy’s dosage for the conditions it ...

Todd Engel, 62, was prescribed Ozempic in 2023 to manage his Type 2 diabetes. The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy ...

The Therapeutic Goods Administration has received complaints of blindness and vision loss in one eye among users of Ozempic and Wegovy, who are reluctant to ditch the weight-loss drugs.

The boss of Ozempic maker Novo Nordisk lost his job yesterday after its share price plunged amid intensifying competition in the multi-billion pound fat jab market. Lars Fruergaard Jorgensen is ...